Top Markets
Coin of the day
Hybio Pharmaceutical Co., Ltd. Hybio Pharmaceutical Co., Ltd.

Hybio Pharmaceutical Co., Ltd.

300199
Rank in Stocks #5169
Established in 1998 and headquartered in Shenzhen, China, Hybio Pharmaceutical... Established in 1998 and headquartered in Shenzhen, China, Hybio Pharmaceutical Co., Ltd. specializes in the global research, development, manufacturing, and commercialization of therapeutic peptide active pharmaceutical ingredients (APIs) and polypeptide medications. Its diverse product range addresses therapeutic needs such as diabetes (including liraglutide, semaglutide, and exenatide), gastrointestinal and metabolic disorders (with examples like terlipressin, desmopressin, and linaclotide), as well as applications in obstetrics and gynecology (featuring ganirelix, cetrorelix, and atosiban). Additionally, the company supplies custom peptides and provides essential working standards for peptide APIs and their impurities, offering comprehensive support for development initiatives. Beyond products, Hybio extends its expertise through Contract Research Organization (CRO) and an extensive Contract Development and Manufacturing Organization (CDMO) platform. This platform covers peptide API synthesis and purification process optimization, finished dosage form conceptualization, reference standard preparation and rigorous qualification, detailed impurity and product quality analysis, Good Manufacturing Practice (GMP) systems adhering to both EU and FDA benchmarks, and comprehensive regulatory and dossier support for both international and Chinese markets.
Share Price
$3.32
Market Cap
$2.93B
Change (1 day)
1.10%
Change (1 year)
-8.99%
Country
CN
Trade Hybio Pharmaceutical Co., Ltd. (300199)

Category

Stock price history for Hybio Pharmaceutical Co., Ltd. (300199)
Highest end of day price: $3.56 on 2026-08-01

Lowest end of day price: $0.58 on 2011-04-01
Stock price history of Hybio Pharmaceutical Co., Ltd. from 2011 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 15.16%
2025 42.29%
2024 -6.38%
2023 -30.94%
2022 109.62%
2021 23.92%
2020 37.43%
2019 -46.61%
2018 -38.55%
2017 -7.67%
2016 -34.21%
2015 61.85%
2014 66.85%
2013 185.59%
2012 -33.66%
2011 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$171.67 -
DE
$164.46 30.68%
DE
$37.78 26.72%
JP
$222.40 27.19%
CH
$21.12 15.66%
IN